Chemical Name: Phenylephrine Related Compound E
Common Names: Phenylephrine Impurity E
Chemical Family: Phenylephrine Derivative
Molecular Formula: Not publicly listed, but classified as a known impurity during the synthesis or degradation of phenylephrine.
Intended Use: Analytical reference standard, pharmaceutical impurity analysis
Physical State: Solid powder or crystalline form
Color and Odor: Often appears as an off-white to pale yellow powder, odorless or faintly characteristic odor
CAS Number: Only a few labs catalog such impurities with specific registration; not generally listed in open chemistry databases.
Synonyms: Specific chemical name based on the structural variant present in phenylephrine manufacturing.
Health Hazards: Unknown long-term toxicity, potential to irritate respiratory tract, skin, or eyes during handling, possible acute toxicity from ingestion or inhalation.
Label Elements: Use laboratory-specific hazard icons due to the impurity status—commonly flagged for irritant qualities.
Precautionary Statements: Avoid breathing dust, wear gloves, goggles, and dust mask.
Environmental Hazards: Persistent chemical, risk of water contamination if not disposed properly; should always prevent uncontrolled release.
Physical Hazards: Not explosive, but fine dust may contribute to air contamination in confined areas.
Main Component: Phenylephrine Related Compound E, purity varies based on isolation method from API or raw materials.
Impurities: May contain trace levels of parent drug, solvent residues from purification stages, and other synthetic byproducts from phenylephrine manufacture.
Concentration: Typically over 95 percent in analytical standards, but lower in industrial waste or intermediates.
Additives: None if prepared under lab conditions; may include stabilizers if supplied for research.
Inhalation: Move to fresh air right away, seek medical attention for any sign of respiratory irritation or distress.
Skin Contact: Remove contaminated clothing, wash affected area thoroughly with plenty of water and mild soap.
Eye Contact: Rinse cautiously with lukewarm water for several minutes, keep eyelids open, consult a healthcare provider for ongoing irritation.
Ingestion: Rinse mouth, do not induce vomiting, seek prompt medical assistance if symptoms appear.
Notes for Clinicians: No established antidote; treat symptomatically, rely on general chemical exposure management protocols.
Suitable Extinguishing Media: Water spray, carbon dioxide, dry chemical powder, foam.
Specific Hazards: May release toxic fumes, such as nitrogen oxides, upon combustion.
Protective Equipment: Firefighters should wear full protective clothing, including NIOSH-approved self-contained breathing apparatus.
Firefighting Tips: Cool exposed containers with water to limit pressure build-up, and keep a safe distance from burning material to avoid inhaling hazardous combustion products.
Spill Response: Wear gloves, goggles, and a dust mask. Avoid dispersing dust into air, gently sweep up spilled powder and place in a secure, labeled waste container.
Environmental Precautions: Prevent entry into drains or surface water, contain with inert absorbent if necessary.
Cleanup Methods: Use damp cloths for small spills, wash site with copious amounts of water after removal, ventilate area.
Waste Disposal: Handle all collected waste as hazardous material, send for incineration or licensed chemical disposal.
Handling Practices: Work in a ventilated space, avoid contact with skin or eyes, do not eat or drink where substance is used.
Storage Conditions: Keep tightly sealed in original container, store in a cool, dry, and well-ventilated area away from strong acids or bases.
Incompatibilities: Avoid reactive metals and oxidizing agents, as uncharacterized reactions could occur.
Storage Security: Restrict access to authorized personnel only, particularly in pharmaceutical and QA/QC labs.
Engineering Controls: Use laboratory fume hoods or local exhaust ventilation to limit airborne exposure.
Personal Protection: Nitrile or latex gloves, lab coat, approved safety goggles, face masks in dusty conditions.
Hygiene Practices: Wash hands thoroughly after use, change out of work clothes if contaminated, never reuse contaminated gloves.
Environmental Controls: Air filtration or scrubbing for any process venting potentially contaminated atmosphere.
Physical Form: Powder or crystals
Color: Off-white, pale yellow
Odor: Not significant
Solubility: Low to moderate solubility in water; soluble in most common organic solvents
Melting Point: Not typically available in public data
pH: Not specified, but expect neutral to slightly acidic in aqueous suspension
Boiling Point: Not commonly available
Vapor Pressure: Not relevant for non-volatile solids
Partition Coefficient: Not widely reported; most pharmaceutical impurities display moderate lipophilicity.
Stability: Stable under recommended handling and storage conditions
Decomposition Products: May generate nitrogen oxides, carbon monoxide, and other irritant fumes when burned or heated excessively
Conditions to Avoid: Exposure to moisture, high temperatures, or strong sunlight
Incompatibility: Strong oxidizers, reactive metals, acids, or bases
Polymerization: No reports of hazardous polymerization under ordinary circumstances.
Acute Toxicity: Limited human data; animal studies for related structures suggest low acute oral and skin toxicity, but irritant or sensitizing effects cannot be ruled out.
Chronic Exposure: No epidemiological data, but pharmaceutical impurities may pose higher risk if not controlled in medications.
Possible Effects: Irritation to eye, skin, and respiratory tract; allergic reactions possible.
Carcinogenicity/Mutagenicity: Unlikely in standard exposure, but long-term studies lacking.
Special Populations: Chemical laboratory staff and those handling pharmaceutical production residues face the greatest risk, especially over long periods or in poorly ventilated sites.
Aquatic Toxicity: Data lacking, but as with many synthetic organics, there’s potential for toxicity in water organisms at higher concentrations.
Degradation: Likely to persist in soil and water for extended periods without specialized breakdown; slow biodegradation rate due to chemical stability.
Bioaccumulation: Unknown but unlikely due to limited solubility, still, best practice is to minimize environmental discharge.
Impact on Sewage Systems: Even small amounts can interfere with biological treatment processes or contaminate water supplies.
Disposal Method: Preferred route is incineration under controlled conditions, handled by licensed chemical waste disposal contractors.
Precautions: Never discharge in drains or mix with domestic waste streams, always segregate for hazardous material handling.
Container Handling: Decontaminate or triple rinse containers before disposal; labels should indicate residual contamination.
Regulatory Guidelines: Follow rules governing pharmaceutical byproduct and impurity disposal defined by local, national, and international agencies.
UN Classification: Typically not classified under standard bulk chemical regulations, as analytical standards are shipped in very small amounts.
Packing Group: Not defined for most pharmaceutical impurities unless shipping exceeds threshold limits.
Special Precautions: Ship in leak-proof, shatter-resistant packaging with full documentation to relevant authorities; avoid shipping with foodstuffs or incompatible chemicals.
Packaging Instructions: Use tamper-evident seals, ship with explicit chemical name and hazard warnings.
Regulatory Status: Not scheduled as an independent drug, but regulated as an impurity in pharmaceutical manufacture; thresholds for reporting or removal stipulated in pharmacopeias.
Lab Reporting: APIs containing related compound E often face tighter scrutiny from regulatory auditors due to impurity limits.
Exposure Standards: No explicit exposure limits set by OSHA, NIOSH, or ACGIH for this compound—general best practices for hazardous dusts apply.
Safe Handling Law: Compliance with Chemical Hazards Communication standards required in workplace; recordkeeping and training for anyone exposed during their routine work.
International Controls: Included in import/export documentation for pharmaceutical manufacturing; labs must maintain strict sample tracking and reporting.